Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Caris Life Sciences Demonstrates Scientific Rigor with Clinical Validation of FDA-Approved MI Cancer Seek(r)

Caris Life Sciences(r) (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, has published a study in Oncotarget validating the analytical and clinical performance of MI Cancer Seek(r).

August 15, 2025


August 26 2025

August 25 2025

August 24 2025

August 23 2025

August 22 2025

August 21 2025

August 20 2025

August 19 2025

August 18 2025

August 17 2025

August 16 2025

August 15 2025

August 14 2025

August 13 2025

August 12 2025